← Open Payments lookup

ISIAKA BOLARINWA: Open Payments

NPI 1467403196 · GLOUCESTER CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,195 in 74 payments from 12 companies in 2025. Trend: 2023 $821 · 2024 $1,158 · 2025 $1,195

Food & beverage: $1,195
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$197
ABBVIE INC.15$193
Alkermes, Inc.12$193
Teva Pharmaceuticals USA, Inc.12$140
E.R. Squibb & Sons, L.L.C.6$105
Janssen Pharmaceuticals, Inc5$96
Otsuka America Pharmaceutical, Inc.4$92
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$55
Supernus Pharmaceuticals, Inc.3$48
Lundbeck LLC2$38

Products named: INGREZZA, VRAYLAR, REXULTI, ARISTADA, COBENFY, LYBALVI, AUSTEDO XR, UZEDY.

Industry payments across NJ — which companies pay providers there.